ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

ATAP Holds Inaugural In-Person Meeting

From the College  |  July 21, 2017

The ACR recently announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the role pharmacy benefit managers (PBMs) play in driving up drug costs. The inaugural ATAP in-person meeting wrapped up on July 19 in Washington, D.C. The Alliance currently consists of the…

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Alliance for Transparent & Affordable Prescriptions (ATAP)California Rheumatology AllianceCoalition of State Rheumatology Organizations (CSRO)Florida Society of RheumatologyGlobal Healthy Living FoundationNew York State Rheumatology Societypharmacy benefit managers (PBMs)

Trump Urges U.S. Senate Republicans to Keep Trying on Healthcare Bill

Amanda Becker and Susan Cornwell  |  July 19, 2017

WASHINGTON (Reuters)—U.S. President Donald Trump pushed Senate Republicans on Wednesday to take another stab at repealing or overhauling Obamacare, urging them at a White House meeting to keep their campaign promises and find a new healthcare approach. “We’re close. We’re very close,” Trump said at the start of the lunch meeting, a day after the…

Filed under:Legislation & Advocacy Tagged with:healthcare billObamacare repealU.S. Senate Republicans

Why We Advocate to Certain Congressional Committees over Others

From the College  |  July 15, 2017

The U.S. Congress refers to the bicameral legislature, consisting of the 435 voting and six non-voting members of the House of Representatives and the 100 members of the Senate. When we visit D.C. or express our policy positions to Congress, our message would ideally reach every member. The ultimate goal is to reach all 535…

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)CongresslawmakerslegislatorRheumatic Disease

Hepatitis Virus, Rheumatic Disease Connection Explored

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—Leonard H. Calabrese, DO, professor of medicine at Cleveland Clinic in Ohio, presented on emerging concepts of viral infections and rheumatic disease at the ACR’s State-of-the-Art Clinical Symposium in April. “We are at a pivotal point in rheumatology in understanding the relationship between viruses and rheumatic disease,” began Dr. Calabrese. “It’s a very exciting time.” Dr. Calabrese…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)comorbiditiesconnectiondirect-acting anti-viralsdrug therapyhepatitisResearchrheumatologysymptomTreatmentVasculitisvirus

Amyloidosis Is Often Underdiagnosed, Undertreated

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—Caryn A. Libbey, MD, clinical associate professor of medicine at Boston University School of Medicine, described the evolving in our understanding of amyloid at the ACR’s State-of-the-Art Clinical Symposium in April. Amyloidosis is a rare disease that is often underdiagnosed and undertreated. “Even though this disease has been around for 150 years, I still consider it…

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)AmyloidosisDiagnosisinflammatory syndromepatient careResearchRheumatic DiseaserheumatologyTreatment

Juvenile-Onset Arthritis Bodes Worse Pregnancy Outcomes

David Douglas  |  July 13, 2017

NEW YORK (Reuters Health)—Women with a diagnosis of juvenile idiopathic arthritis (JIA) are at increased risk of pregnancy complications, according to Swedish researchers. As Dr. Katarina Remaeus told Reuters Health by email, “In our cohort study . . . we found an association with adverse pregnancy outcomes including preterm birth, induction of labor and delivery…

Filed under:Conditions Tagged with:juvenile idiopathic arthritis (JIA)pregnancy complicationspreterm birth

Tofacitinib with Methotrexate Not Inferior to Adalimumab with Methotrexate

Thomas R. Collins  |  July 13, 2017

Highlights from the 2017 EULAR Congress MADRID—Tofacitinib (a JAK inhibitor) used with methotrexate (MTX) is not inferior to adalimumab (a TNF inhibitor) plus MTX in rheumatoid arthritis (RA) patients who’ve had an inadequate response to MTX alone, according to results of a Phase 3B/4 trial presented in a session at the Annual European Congress of…

Filed under:Drug UpdatesMeeting Reports Tagged with:EULAR

How to Document a Patient’s Medical History

From the College  |  July 13, 2017

The levels of service within an evaluation and management (E/M) visit are based on the documentation of key components, which include history, physical examination and medical decision making. The history component is comparable to telling a story and should include a beginning and some form of development to adequately describe the patient’s presenting problem. To…

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCenters for Medicare & Medicaid Services (CMS)CodingDocumentationguidelineoffice visitpatient carephysicianpractice management. evaluationReimbursementrheumatologistrheumatology

How Global Geographic Disparities Affect Healthcare Outcomes

Simon M. Helfgott, MD  |  July 13, 2017

Your home & your health: Does geography impact medicine? Does it matter whether a region is surrounded by large bodies of water, encircled by towering mountain peaks or that its residents share a common ancestry? Consider Switzerland, a nation with a highly developed economy replete with advanced technological and medical infrastructure. Despite these advantages, less…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:cost of health careDiseaseDisparitiesgeographyglobalHealth InsuranceHealthcareInternationallife expectancymedicinepublic healthrheumatologyTechnology

Opana ER Pulled from U.S. Market

Michele B. Kaufman, PharmD, BCGP  |  July 11, 2017

Endo Pharmaceuticals will work with the FDA to coordinate the organized removal of Opana ER from the U.S. market.

Filed under:AnalgesicsDrug Updates Tagged with:Drug SafetyOpana ERopioidOpioid abuse

  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 128
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences